FDA Releases Guidance on Handling and Retention of Bioavailability and Bioequivalence Testing Samples

Summary

The FDA has published a guidance document outlining procedures for handling and retaining reserve samples from bioavailability and bioequivalence studies for new drug applications, abbreviated new drug applications, and contract research organizations.